Akèy › Twoub Metabolik
Etid klinik pou Twoub Metabolik ap rekrite nan Etazini
54 etid pou Twoub Metabolik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Washington, DC11 etid
- Ann Arbor, MI8 etid
- St. Louis, MO7 etid
- New York City, NY7 etid
- Durham, NC7 etid
- Baltimore, MD6 etid
- Houston, TX6 etid
- Chicago, IL6 etid
- Boston, MA5 etid
- Philadelphia, PA4 etid
- Seattle, WA4 etid
- Los Angeles, CA4 etid
- Miami, FL4 etid
- Nashville, TN4 etid
- Cleveland, OH3 etid
- Fort Collins, CO3 etid
- Aurora, CO3 etid
- Sacramento, CA3 etid
- Rochester, NY3 etid
- Escondido, CA3 etid
- Town 'n' Country, FL3 etid
- Louisville, KY3 etid
- Albuquerque, NM3 etid
- Cincinnati, OH3 etid
- San Antonio, TX3 etid
- Simi Valley, CA3 etid
- Mountain View, CA3 etid
- Pittsburgh, PA3 etid
- Fresno, CA3 etid
- Orlando, FL3 etid
- Hialeah, FL3 etid
- Jacksonville, FL3 etid
- Rochester, MN3 etid
- Birmingham, AL3 etid
Pa eta
- Alabama3 etid
- Colorado7 etid
- Florid7 etid
- Illinois6 etid
- Indiana5 etid
- Kalifòni12 etid
- Kentucky3 etid
- Lwizyàn3 etid
- Maryland15 etid
- Massachusetts8 etid
- Michigan10 etid
- Minnesota3 etid
- Missouri7 etid
- New Mexico3 etid
- New York11 etid
- North Carolina9 etid
- Ohio6 etid
- Pennsylvania5 etid
- Tennessee4 etid
- Texas7 etid
- Virginia4 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 100 Years · Tout sèks · Mizajou Sep 28, 2026 · NCT02890342Natural History of the Human Biological Response to Environmental Exposure and Injury
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT04888923Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 1 a 100 · Tout sèks · Mizajou Sep 22, 2026 · NCT01143454A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06525636A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07491172Use of Cysteamine in the Treatment of Cystinosis
Ap rekriteEtid obsèvasyon
1 Week – 115 Years · Tout sèks · Mizajou Sep 16, 2026 · NCT00359684Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
Ap rekriteEtid obsèvasyon
Laj 2 a 40 · Gason · Mizajou Sep 16, 2026 · NCT05600946Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Ap rekriteFaz 1/2
Jiska laj 20 · Tout sèks · Mizajou Sep 16, 2026 · NCT00920972A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07723833A Natural History Study of Metabolic Sizing in Health and Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 99 · Tout sèks · Mizajou Sep 15, 2026 · NCT05398783METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Ap rekriteFaz 2
Laj 18 a 69 · Tout sèks · Mizajou Sep 15, 2026 · NCT07699380Clinical and Laboratory Study of Methylmalonic Acidemia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Month – 115 Years · Tout sèks · Mizajou Sep 10, 2026 · NCT00078078Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Ap rekriteEtid obsèvasyon
1 Month – 115 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT00001456Improving Coronary Vascular Health in Women
Ap rekriteFaz 2
Laj 45 a 75 · Fanm · Mizajou Sep 8, 2026 · NCT06843902Impact of NMES and HPRO on Recovery After SAH- Pilot Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT03201094A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Ap rekriteEtid obsèvasyon
7 Months – 15 Months · Tout sèks · Mizajou Aug 31, 2026 · NCT06805695A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Ap rekriteFaz 1/2
Laj 35 a 70 · Tout sèks · Mizajou Aug 21, 2026 · NCT06575426A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Ap rekriteEtid obsèvasyon
1 Month – 100 Years · Tout sèks · Mizajou Aug 19, 2026 · NCT06092346Evaluation of Children With Endocrine and Metabolic-Related Conditions
Ap rekriteEtid obsèvasyon
3 Months – 100 Years · Tout sèks · Mizajou Aug 13, 2026 · NCT02769975Blood Specimen Collection For Laboratory Assay Research
Ap rekriteEtid obsèvasyonMande peman pou patisipan yo
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT06046651NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT04055428Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 14 a 18 · Tout sèks · Mizajou Jul 13, 2026 · NCT06007404Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.